Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes:: in vitro and in vivo studies

被引:112
作者
Khan, A
Benboubetra, M
Sayyed, PZ
Ng, KW
Fox, S
Beck, G
Benter, IF
Akhtar, S
机构
[1] Cardiff Univ, Welsh Sch Pharm, Ctr Genome Based Therapeut, Cardiff CF10 3XF, S Glam, Wales
[2] Aston Univ, Pharmaceut Sci Res Inst, Birmingham BA4 7ET, W Midlands, England
[3] Univ Setif, Fac Sci, Lab Appl Biochem, Setif, Algeria
[4] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[5] Kuwait Univ, Fac Med, Dept Pharmacol, Kuwait, Kuwait
关键词
antisense oligonucleotides; siRNA; DNA enzymes; RNA enzyme; whole body autoradiography; PLGA; microspheres;
D O I
10.1080/10611860400003858
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Small interfering RNA (siRNA), antisense oligonucleotides (ODNs), ribozymes and DNAzymes have emerged as sequence-specific inhibitors of gene expression that may have therapeutic potential in the treatment of a wide range of diseases. Due to their rapid degradation in vivo, the efficacy of naked gene silencing nucleic acids is relatively short lived. The entrapment of these nucleic acids within biodegradable sustained-release delivery systems may improve their stability and reduce the doses required for efficacy. In this study, we have evaluated the potential in vitro and in vivo use of biodegradable poly (D,L-lactide-co-glycolide) copolymer (PLGA) microspheres as sustained delivery devices for ODNs, ribozyme, siRNA and DNA enzymes. In addition, we investigated the release of ODN conjugates bearing 5'-end lipophilic groups. The in vitro sustained release profiles of microsphere-entrapped nucleic acids were dependent on variables such as the type of nucleic acid used, the nature of the lipophilic group, and whether the nucleic acid used was single or double stranded. For in vivo studies, whole body autoradiography was used to monitor the bio-distribution of either free tritium-labelled ODN or that entrapped within PLGA microspheres following subcutaneous administration in Balb-c mice. The majority of the radioactivity associated with free ODN was eliminated within 24 h whereas polymer-released ODN persisted in organs and at the site of administration even after seven days post-administration. Polymer microsphere released ODN exhibited a similar tissue and cellular tropism to the free ODN. Micro-autoradiography analyses of the liver and kidneys showed similar bio-distribution for polymer-released and free ODNs with the majority of radioactivity being concentrated in the proximal convoluted tubules of the kidney and in the Kupffer cells of the liver. These findings suggest that biodegradable PLGA microspheres offer a method for improving the in vivo sustained delivery of gene silencing nucleic acids, and hence are worthy of further investigation as delivery systems for these macromolecules.
引用
收藏
页码:393 / 404
页数:12
相关论文
共 50 条
[1]   Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres [J].
Akhtar, S ;
Lewis, KJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 151 (01) :57-67
[2]   The delivery of antisense therapeutics [J].
Akhtar, S ;
Hughes, MD ;
Khan, A ;
Bibby, M ;
Hussain, M ;
Nawaz, Q ;
Double, J ;
Sayyed, P .
ADVANCED DRUG DELIVERY REVIEWS, 2000, 44 (01) :3-21
[3]  
Alvarez-Salas LM, 2003, ANTIVIR THER, V8, P265
[4]   Gene silencing nucleic acids designed by scanning arrays: Anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system [J].
Beale, G ;
Hollins, AJ ;
Benboubetra, M ;
Sohail, M ;
Fox, SP ;
Benter, I ;
Akhtar, S .
JOURNAL OF DRUG TARGETING, 2003, 11 (07) :449-456
[5]   Chemically modified hammerhead ribozymes with improved catalytic rates [J].
Burgin, AB ;
Gonzalez, C ;
MatulicAdamic, J ;
Karpeisky, AM ;
Usman, N ;
McSwiggen, JA ;
Beigelman, L .
BIOCHEMISTRY, 1996, 35 (45) :14090-14097
[6]   Distribution of the cellular uptake of phosphorothioate oligodeoxynucleotides in the rat kidney in vivo [J].
Carome, MA ;
Kang, YH ;
Bohen, EM ;
Nicholson, DE ;
Carr, FE ;
Kiandoli, LC ;
Brummel, SE ;
Yuan, CM .
NEPHRON, 1997, 75 (01) :82-87
[7]  
COHEN I, 1991, PHARM RES, V28, P2018
[8]  
CURTIS CG, 1981, WHOLE BODY AUTORADIO
[9]   Hepatic diseases - Hitting the target with inhibitory RNAs [J].
Davidson, BL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (24) :2357-2359
[10]   Killing the messenger: Short RNAs that silence gene expression [J].
Dykxhoorn, DM ;
Novina, CD ;
Sharp, PA .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (06) :457-467